{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:21:59Z","timestamp":1785860519375,"version":"3.56.0"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreas"],"published-print":{"date-parts":[[1986,1]]},"DOI":"10.1097\/00006676-198601000-00010","type":"journal-article","created":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T04:15:36Z","timestamp":1143778536000},"page":"49-54","source":"Crossref","is-referenced-by-count":3,"title":["Combined Effects of \u03b1-Difluoromethylornithine and Doxorubicin Against Pancreatic Cancer Cell Lines in Culture"],"prefix":"10.1097","volume":"1","author":[{"given":"Barbara K.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Owen","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006676-198601000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:26:15Z","timestamp":1785857175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006676-198601000-00010"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1986,1]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1097\/00006676-198601000-00010","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[1986,1]]}}}